Effect of Intensive Cognitive Rehabilitation in Subacute Stroke Patient

Early stroke rehabilitation is known to be an effective and essential therapy in gaining functional independence and preventing complications. However, there was no consensus of proper amount of cognitive rehabilitation in stroke patients. In this study, the investigators assess the effects of the intensive cognitive rehabilitation during subacute phase to improve cognitive function at 6 months after onset in patients with first-ever strokes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Cognitive Function Nervous System Diseases Rehabilitation Vascular Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Samsung Medical Center

Seoul, 135-710, South Korea

About this study

Intensive cognitive rehabilitation group

cognitive therapy for 1 hours on every working day for 4 weeks

Conventional cognitive rehabilitation group

cognitive therapy for 30 minutes on every working day for 4 weeks

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Acute first-ever stroke
Korean Mini-Mental State Examination: 11~24 at 7 days after stroke onset

Exclusion criteria

Transient ischemic stroke

Treatment and study plan

Cognitive rehabilitation

Procedure

Intensive cognitive rehabilitation by cognitive therapist for 1 hours on every working day during subacute stroke phase

Primary outcomes

Korean-Montreal Cognitive Assessment (K-MoCA)

Time frame: Change of K-MoCa after intensive cognitive rehabilitation for 4 weeks

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Important dates

Study start: 2016
Primary completion: 2023
Study completion: 2023
First posted: May 30, 2017
Registry last updated: Mar 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed